Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibandronate vs zoledronic acid for metastatic bone pain
2004-002131-12Phase 2Completed
- Sponsor
- Roche
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ibandronic acid in bone metastases and Non-hematologic malignancy (2 arms), sponsored by Roche. Primary endpoints: Analgesic efficacy on metastatic bone pain and Safety and tolerability. Started Aug 2005; status: completed.
02
Drugs
ibandronic acid
03
Conditions
bone metastasesNon-hematologic malignancy
Beyond the preview
Go deeper on 2004-002131-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002131-12.